General information about company
Scrip code	524654
NSE Symbol
MSEI Symbol
ISIN*	INE936B01015
Name of company	Natural Capsules Limited
Type of company
Class of security	Equity
Date of start of financial year	01-04-2022
Date of end of financial year	31-03-2023
Date of board meeting when results were approved	28-10-2022
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	21-10-2022
Description of presentation currency	INR
Level of rounding used in financial results	Lakhs
Reporting Quarter	Half yearly
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited	Unaudited
Segment Reporting	Single segment
Description of single segment	Pharmaceutical
Start date and time of board meeting	28-10-2022 16:00
End date and time of board meeting	28-10-2022 19:10
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Not applicable

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-07-2022	01-04-2022
B	Date of end of reporting period	30-09-2022	30-09-2022
C	Whether results are audited or unaudited	Unaudited	Unaudited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	4506	8925
	Other income	4	25
	Total income	4510	8950
2	Expenses
(a)	Cost of materials consumed	2024	4103
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-33	-106
(d)	Employee benefit expense	269	532
(e)	Finance costs	72	134
(f)	Depreciation, depletion and amortisation expense	196	359
(f)	Other Expenses
1	Other Expenses	1279	2512
10
	Total other expenses	1279	2512
	Total expenses	3807	7534

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-07-2022	01-04-2022
B	Date of end of reporting period	30-09-2022	30-09-2022
C	Whether results are audited or unaudited	Unaudited	Unaudited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
3	Total profit before exceptional items and tax	703	1416
4	Exceptional items	0	0
5	Total profit before tax	703	1416
7	Tax expense
8	Current tax	156	323
9	Deferred tax	13	35
10	Total tax expenses	169	358
11	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
14	Net Profit Loss for the period from continuing operations	534	1058
15	Profit (loss) from discontinued operations before tax	0	0
16	Tax expense of discontinued operations	0	0
17	Net profit (loss) from discontinued operation after tax	0	0
19	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
21	Total profit (loss) for period	534	1058
22	Other comprehensive income net of taxes	0	0

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-07-2022	01-04-2022
B	Date of end of reporting period	30-09-2022	30-09-2022
C	Whether results are audited or unaudited	Unaudited	Unaudited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
23	Total Comprehensive Income for the period	534	1058
24	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
25	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	0	0
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0	0
26	Details of equity share capital
	Paid-up equity share capital	779	779
	Face value of equity share capital	10	10
27	Details of debt securities
28	Reserves excluding revaluation reserve
29	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	6.87	13.61
	Diluted earnings (loss) per share from continuing operations	6.87	13.61
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	6.87	13.61
	Diluted earnings (loss) per share from continuing and discontinued operations	6.87	13.61
30	Debt equity ratio	0.8	0.8
31	Debt service coverage ratio
32	Interest service coverage ratio
33	Disclosure of notes on financial results

Statement of Asset and Liabilities
Particulars		Half year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2022
Date of end of reporting period		30-09-2022
Whether results are audited or unaudited		Unaudited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	7301.72
	Capital work-in-progress	819.9
	Investment property	0
	Goodwill	0
	Other intangible assets	164.1
	Intangible assets under development
	Biological assets other than bearer plants
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	2000.75
	Trade receivables, non-current	0
	Loans, non-current	617.18
	Other non-current financial assets	201.87
	Total non-current financial assets	2819.8
	Deferred tax assets (net)	0
	Other non-current assets	0
	Total non-current assets	11105.52
2	Current assets
	Inventories	496.95
	Current financial asset
	Current investments	0
	Trade receivables, current	4491.06
	Cash and cash equivalents	39.98
	Bank balance other than cash and cash equivalents	263.64
	Loans, current	20
	Other current financial assets	51.86
	Total current financial assets	4866.54
	Current tax assets (net)	0
	Other current assets	1769.46
	Total current assets	7132.95

Statement of Asset and Liabilities
Particulars		Half year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2022
Date of end of reporting period		30-09-2022
Whether results are audited or unaudited		Unaudited
Nature of report standalone or consolidated		Standalone
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	18238.47
	Equity and liabilities
	Equity
	Equity attributable to owners of parent
	Equity share capital	777.17
	Other equity	9346.09
	Total equity attributable to owners of parent	10123.26
	Non controlling interest
	Total equity	10123.26
	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	1759.02
	Trade payables, non-current
	Other non-current financial liabilities	41.94
	Total non-current financial liabilities	1800.96
	Provisions, non-current	8
	Deferred tax liabilities (net)	203.7
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	2012.66
	Current liabilities
	Current financial liabilities
	Borrowings, current	1945.76
	Trade payables, current	2192.84
	Other current financial liabilities	16.88
	Total current financial liabilities	4155.48
	Other current liabilities	1582.45
	Provisions, current	79.08
	Current tax liabilities (Net)	285.54
	Deferred government grants, Current	0
	Total current liabilities	6102.55
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	8115.21
	Total equity and liabilites	18238.47
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-07-2022	01-04-2022
Date of end of reporting period		30-09-2022	30-09-2022
Whether accounts are audited or unaudited		Unaudited	Unaudited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets
	Net Segment Asset
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities
	Net Segment Liabilities
	Disclosure of notes on segments

Cash flow statement, indirect
Particulars		6 months ended (dd-mm-yyyy)
A	Date of start of reporting period	01-04-2022
B	Date of end of reporting period	30-09-2022
C	Whether results are audited or unaudited	Unaudited
D	Nature of report standalone or consolidated	Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax	1416
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs	133.98
	Adjustments for decrease (increase) in inventories	-39.14
	Adjustments for decrease (increase) in trade receivables, current	-1861.87
	Adjustments for decrease (increase) in trade receivables, non-current	0
	Adjustments for decrease (increase) in other current assets	2567.83
	Adjustments for decrease (increase) in other non-current assets	0
	Adjustments for other financial assets, non-current	-3.42
	Adjustments for other financial assets, current	0
	Adjustments for other bank balances	-92.62
	Adjustments for increase (decrease) in trade payables, current	430.56
	Adjustments for increase (decrease) in trade payables, non-current	0
	Adjustments for increase (decrease) in other current liabilities	810.87
	Adjustments for increase (decrease) in other non-current liabilities	0
	Adjustments for depreciation and amortisation expense	359.16
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss	0
	Adjustments for provisions, current	207.99
	Adjustments for provisions, non-current	0.01
	Adjustments for other financial liabilities, current	-0.36
	Adjustments for other financial liabilities, non-current	0
	Adjustments for unrealised foreign exchange losses gains	0
	Adjustments for dividend income	0
	Adjustments for interest income	0
	Adjustments for share-based payments	0
	Adjustments for fair value losses (gains)	0
	Adjustments for undistributed profits of associates	0
	Other adjustments for which cash effects are investing or financing cash flow	0
	Other adjustments to reconcile profit (loss)	-4.54
	Other adjustments for non-cash items	1.08
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships	0
	Total adjustments for reconcile profit (loss)	2509.53
	Net cash flows from (used in) operations	3925.53
	Dividends received	0
	Interest paid	0
	Interest received	-8.42
	Income taxes paid (refund)	323.13
	Other inflows (outflows) of cash	0
	Net cash flows from (used in) operating activities	3593.98
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses	0
	Cash flows used in obtaining control of subsidiaries or other businesses	0
	Other cash receipts from sales of equity or debt instruments of other entities	0
	Other cash payments to acquire equity or debt instruments of other entities	0
	Other cash receipts from sales of interests in joint ventures	0
	Other cash payments to acquire interests in joint ventures	0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships	0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships	0
	Proceeds from sales of property, plant and equipment	0
	Purchase of property, plant and equipment	2297.67
	Proceeds from sales of investment property	0
	Purchase of investment property	0
	Proceeds from sales of intangible assets	58.48
	Purchase of intangible assets	0
	Proceeds from sales of intangible assets under development	0
	Purchase of intangible assets under development	0
	Proceeds from sales of goodwill	0
	Purchase of goodwill	0
	Proceeds from biological assets other than bearer plants	0
	Purchase of biological assets other than bearer plants	0
	Proceeds from government grants	0
	Proceeds from sales of other long-term assets	0
	Purchase of other long-term assets	0
	Cash advances and loans made to other parties	669.04
	Cash receipts from repayment of advances and loans made to other parties	0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts	0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts	0
	Dividends received	0
	Interest received	8.42
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	-1995.28
	Net cash flows from (used in) investing activities	-4895.09
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries	0
	Payments from changes in ownership interests in subsidiaries	0
	Proceeds from issuing shares	759.88
	Proceeds from issuing other equity instruments	0
	Payments to acquire or redeem entity's shares	0
	Payments of other equity instruments	0
	Proceeds from exercise of stock options	0
	Proceeds from issuing debentures notes bonds etc	0
	Proceeds from borrowings	596.62
	Repayments of borrowings	0
	Payments of finance lease liabilities	9.53
	Payments of lease liabilities	0
	Dividends paid	0
	Interest paid	133.98
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	0
	Net cash flows from (used in) financing activities	1212.99
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes	-88.12
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents	0
	Net increase (decrease) in cash and cash equivalents	-88.12
	Cash and cash equivalents cash flow statement at beginning of period	127.79
	Cash and cash equivalents cash flow statement at end of period	39.67